Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Cancer-associated mesothelial cell–derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis
Preety Bajwa, Kasjusz Kordylewicz, Agnes Bilecz, Ricardo R. Lastra, Kristen Wroblewski, Yuval Rinkevich, Ernst Lengyel, Hilary A. Kenny
Preety Bajwa, Kasjusz Kordylewicz, Agnes Bilecz, Ricardo R. Lastra, Kristen Wroblewski, Yuval Rinkevich, Ernst Lengyel, Hilary A. Kenny
View: Text | PDF
Research Article Cell biology Oncology

Cancer-associated mesothelial cell–derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis

  • Text
  • PDF
Abstract

Ovarian cancer (OvCa) preferentially metastasizes in association with mesothelial cell–lined surfaces. We sought to determine if mesothelial cells are required for OvCa metastasis and detect alterations in mesothelial cell gene expression and cytokine secretion upon interaction with OvCa cells. Using omental samples from patients with high-grade serous OvCa and mouse models with Wt1-driven GFP-expressing mesothelial cells, we validated the intratumoral localization of mesothelial cells during human and mouse OvCa omental metastasis. Removing mesothelial cells ex vivo from human and mouse omenta or in vivo using diphtheria toxin-mediated ablation in Msln-Cre mice significantly inhibited OvCa cell adhesion and colonization. Human ascites induced angiopoietin-like 4 (ANGPTL4) and stanniocalcin 1 (STC1) expression and secretion by mesothelial cells. Inhibition of STC1 or ANGPTL4 via RNAi obstructed OvCa cell-induced mesothelial cell to mesenchymal transition while inhibition of ANGPTL4 alone obstructed OvCa cell-induced mesothelial cell migration and glycolysis. Inhibition of mesothelial cell ANGPTL4 secretion via RNAi prevented mesothelial cell–induced monocyte migration, endothelial cell vessel formation, and OvCa cell adhesion, migration, and proliferation. In contrast, inhibition of mesothelial cell STC1 secretion via RNAi prevented mesothelial cell–induced endothelial cell vessel formation and OvCa cell adhesion, migration, proliferation, and invasion. Additionally, blocking ANPTL4 function with Abs reduced the ex vivo colonization of 3 different OvCa cell lines on human omental tissue explants and in vivo colonization of ID8p53–/–Brca2–/– cells on mouse omenta. These findings indicate that mesothelial cells are important to the initial stages of OvCa metastasis and that the crosstalk between mesothelial cells and the tumor microenvironment promotes OvCa metastasis through the secretion of ANGPTL4.

Authors

Preety Bajwa, Kasjusz Kordylewicz, Agnes Bilecz, Ricardo R. Lastra, Kristen Wroblewski, Yuval Rinkevich, Ernst Lengyel, Hilary A. Kenny

×

Figure 3

OvCa cells induce secretome and transcriptome changes in primary human mesothelial cells.

Options: View larger image (or click on image) Download as PowerPoint
OvCa cells induce secretome and transcriptome changes in primary human m...
(A) Mesothelial cells were treated with control media (Control), Tyk-nu OvCa CM, or human ascites (ASC) for 36 hours. The mesothelial cells were washed, and serum-free media was added for 24 hours. Human Cytokine Arrays were performed. One of the 4 biological replicates of each treatment are shown (left). Quantification using ImageJ software (right). Data are shown as the mean ± SEM. *P < 0.05 and **P < 0.01 by paired Student’s t test comparisons. (B–D) Mesothelial cells were treated with Control, OvCa CM, or ASC from 3 different patients (n = 10). RNA was isolated from the mesothelial cells and RNA-Seq analysis was performed. Volcano plots annotated with top 10 significantly upregulated transcripts in the OvCa CM in B or ASC-treated mesothelial cells in C. (D) Pearson’s correlation coefficient analysis of ANGPTL4 and STC1 RNA levels in control versus ascites-treated mesothelial cells from this experiment. (E and F) Mesothelial cells were treated with control media (Control), OvCa CM, or ASC. RNA was isolated from the mesothelial cells, or mesothelial cell CM was collected. ANGPTL4 in E and STC1 expression and secretion in F was quantified using reverse transcription-qPCR (qRT-PCR) (n = 7 patients in OvCa CM group and n = 6 patients in ASC group) or enzyme-linked immunostaining assays. Data are represented as the mean ± SEM (n = 6). *P < 0.05 and **P < 0.01 calculated using paired 2-tailed Student’s t test comparisons. (G and H) Mesothelial cells were treated with an IL-6–neutralizing Ab or control Ab (Control IgG) in the presence of ASC. Mesothelial cells were washed, serum-free media was added, and the mesothelial cell CM was collected. Analysis of ANGPTL4 in G and STC1 secretion in H using ANGPTL4- or STC1-specific enzyme linked immunostaining assays. Data are shown as the mean ± SEM (n = 7). **P < 0.01 and ***P < 0.001 by 1-way ANOVA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts